Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Breeding & Genetics Contract Win

12 Jul 2016 07:00

RNS Number : 8661D
Benchmark Holdings PLC
12 July 2016
 

RNS Reach

 

Benchmark Holdings plc("Benchmark" or the "Company")

 

Contract win for Breeding & Genetics division

 

Benchmark Holdings announces that a subsidiary of its Breeding & Genetics division SalmoBreed AS ("SalmoBreed") has signed a ten-year agreement with Lerøy Aakvik Roe and Stamfisk AS ("Lerøy") - one of the world's top three salmon producers - for the supply of the SalmoBreed genetic stem into its production sites. The agreement will see the Lerøy team start breeding with SalmoBreed's genetic lines, producing SalmoBreed strain ova for sale to companies within the Lerøy Group.

 

The agreement will not make a material financial contribution to Benchmark in the short term, however the Directors believe that it is of strategic importance to Benchmark's position in the market. This contract represents an endorsement of SalmoBreed's ability to produce world-class salmon strains, and is an encouraging collaboration with one of the largest producers in the industry.

 

Benchmark's CEO, Malcolm Pye, commented:

 

"We are very pleased to have reached this agreement with such a prominent player in the space, which is testament to the great work being done at SalmoBreed and in our Breeding & Genetics division as a whole. The opportunity to collaborate with Lerøy and have SalmoBreed's genetic lines distributed to its Group establishes SalmoBreed's position as an industry leader."

 

 

-ENDS-

 

Benchmark Holdings plc

Tel: +44 (0)1142 409939

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

Tel: +44 (0)1865 790880

 

Numis

 

Tel: +44 (0)2072 601000

Michael Meade/Freddie Barnfield (NOMAD)

James Black / Tom Ballard (Corporate Broking)

Tavistock

Tel: +44 (0)2079 203150

Matt Ridsdale/Niall Walsh

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRARBMFTMBBBBTF
Date   Source Headline
19th Mar 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
26th Feb 202110:52 amRNSTotal Voting Rights
22nd Feb 20217:00 amRNSQ1 Results
9th Feb 202112:43 pmRNSResult of AGM
9th Feb 20217:00 amRNSNotice of Q1 Results
29th Jan 20217:00 amRNSTotal Voting Rights
13th Jan 20217:00 amRNSIssue of Equity
8th Jan 20211:13 pmRNSReplacement: DIRECTOR SHARE OPTIONS
8th Jan 20219:57 amRNSDIRECTOR SHARE OPTIONS
6th Jan 20213:45 pmRNSDirector Dealings
31st Dec 20207:00 amRNSTotal Voting Rights
11th Dec 20205:32 pmRNSPosting of Annual Report and Notice of AGM
2nd Dec 20202:09 pmRNSDirector Dealings
1st Dec 20204:02 pmRNSAnnual Financial Report
1st Dec 202011:30 amRNSDirector Dealings
1st Dec 202010:30 amRNSDirector Dealings
1st Dec 202010:21 amRNSPCA Dealing
30th Nov 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSQ4 Results
27th Nov 20207:00 amRNSFull Year Results
18th Nov 20207:00 amRNSDirectorate Change
4th Nov 20207:00 amRNSInvestor Presentation for Retail Investors
30th Oct 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNotice of Results
13th Oct 20202:29 pmRNSHolding(s) in Company
12th Oct 20202:50 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.